[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100506266":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":34,"locations":43,"responsibleParty":59,"collaborators":12,"id":61,"slug":12,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":66,"eligibilityCriteria":67,"healthyVolunteers":62,"sex":68,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":12,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":46,"whyStopped":12,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"University Hospital, Caen","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard care","NO_INTERVENTION","Standard care are defined by routine procedures implemented in each center to prevent and control the diffusion of MDR-E bacteria in ICUs. In the first period of the study, the frequency of cross transmission will be assessed by sequencing the first ESBL-E isolate in each carrier patients (first isolate of a given species)",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Transmission of FTIR results","EXPERIMENTAL","In second phase of the study, the result of FTIR typing of recovered ESBL-E isolates will be weekly transmitted to participating centers.",[18],"Diagnostic Test: FTIR results",[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":12},"DIAGNOSTIC_TEST","FTIR results","Weekly transmission of FTIRS typing of ESBL-E to centers",[14],[26,30],{"name":27,"affiliation":28,"role":29},"Camille Jeanne-Leroyer, PharmD","Caen Normandie Hospital","PRINCIPAL_INVESTIGATOR",{"name":31,"affiliation":32,"role":33},"Olivier Join-Lambert, MD, PhD","Caen Normandie University and Hospital","STUDY_DIRECTOR",[35,40],{"name":36,"role":37,"phone":38,"phoneExt":12,"email":39},"Camille Jeanne-Leroyer","CONTACT","+33(0)231065947","jeanneleroyer-c@chu-caen.fr",{"name":31,"role":37,"phone":41,"phoneExt":12,"email":42},"+33(0)231064895","olivier.join-lambert@unicaen.fr",[44],{"facility":45,"status":46,"city":47,"state":12,"zip":12,"country":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"CHU CHEN","RECRUITING","Caen","France",{"type":50,"coordinates":51},"Point",[52,53],-0.35912,49.18585,{"lat":53,"lon":52},[56],{"name":57,"role":37,"phone":12,"phoneExt":12,"email":58},"JOIN LAMBERT","jointlambert-o@chu-caen.fr",{"type":60,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR","100506266",false,"NCT05872152","Impact of Fourier Transform Infrared Spectroscopy (FTIRS) in ICUs","Impact of Fourier Transform Infrared Spectroscopy (FTIRS) on the Diffusion of ESBL Producing Enterobacterales in Intensive Care Units (ICU)","ECLA'IR","Inclusion Criteria:\n\n* Adult patients hospitalized in ICU\n* ESBL-E carrier\n\nExclusion Criteria:\n\n* none","ALL","18 Years","100 Years",{"count":72,"type":73},900,"ESTIMATED","INTERVENTIONAL",[76],"NA","This study will assess the impact of FTIRS typing on the spread of ESBL-E in intensive care units",[79],"Organ Failure, Multiple",[81,82,83,84,85],"multidrug resistant bacteria","outbreak","prevention and infection control","bacterial typing","Fourier transform infrared spectroscopy","2025-07-21",{"date":88,"type":89},"2025-07-24","ACTUAL",{"date":91,"type":89},"2024-01-08",{"date":93,"type":73},"2026-09-01",{"name":5,"class":6},1]